Chemotherapy Is One Of The Main Ways To Treat Cancer – Part 3 of 3
Those in the combination groups were more likely to have no breast cancer cells found at surgery than those in the standard groups. While 42 percent of those in the standard group had no breast cancer cells identified at surgery, 50 percent to 67 percent of those in the society groups did not. Genentech, which makes Avastin, funded Sikov’s study. Other supporters included the US National Institutes of Health and the Breast Cancer Research Foundation.
The into or presented by Rugo is funded by a variety of sources, included unrestricted funding from several pharmaceutical companies. “Every fix we have studies like this, it tells us we are on to something,” said Dr Joanne Mortimer, director of women’s cancer programs at the City of Hope Comprehensive Cancer Center, in Duarte, California She reviewed the findings. While the approaches back up further investigation, she cautions that ”both these studies have very small numbers”.
Complicating the issue is that “triple-negative is not a single disease”. There are several subtypes, and patients counter differently to treatments. “This research is very interesting, but until we know which actual specific patient’s tumors are going to benefit, it’s hard to apply this to the population”. Studies presented at medical conferences are considered or technical prodromal since they have not yet had the independent scrutiny required for publication in most medical journals.